Studies raise concerns that taking anemia drugs after chemo may be harmful

02/27/2007 |

Anemia drugs sold by Amgen, Johnson & Johnson and Roche could be harming some cancer patients instead of helping them, new studies conclude. The drugs are used to treat anemia that results from chemotherapy, but the studies suggest use of those drugs for that purpose may make the cancer worse. Amgen said its anemia drug was safe and effective when used as intended.

View Full Article in:

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT